Novel insulin-sensitizing nash/diabetes drugs
Ended Project Grant Awarded Last action
- Award ID
- R42DK121652
- Recipient
-
Bioio, Inc. UEI NCX4S2YKK6A8
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,208,973
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Funding
-
- $2,711,447.00 Federal
- $497,526.00 Non-federal
- Place of performance
- Missouri, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $497,526 | $0 | |
| Amendment | $497,526 | $0 | |
| Amendment | $497,526 | $0 | |
| Amendment | $497,526 | $497,526 | |
| Amendment | $497,526 | $0 | |
| Original award | $223,817 | $0 |
Quick answers
Who received award R42DK121652?
R42DK121652 was awarded to Bioio, Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 17, 2019.
How much is award R42DK121652 worth?
$3,208,973 has been obligated on R42DK121652: $2,711,447 in federal funding and $497,526 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award